ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Study of Retatrutide (LY3437943) Compared to Tirzepatide (LY3298176) in Adults Who Have Obesity

ClinicalTrials.gov ID: NCT06662383

Public ClinicalTrials.gov record NCT06662383. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Retatrutide Compared to Tirzepatide in Adults Who Have Obesity

Study identification

NCT ID
NCT06662383
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
800 participants

Conditions and interventions

Conditions

Interventions

  • Retatrutide Drug
  • Tirzepatide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2024
Primary completion
Nov 30, 2026
Completion
Nov 30, 2026
Last update posted
Apr 12, 2026

2024 – 2026

United States locations

U.S. sites
40
U.S. states
22
U.S. cities
38
Facility City State ZIP Site status
Medical Advancement Centers of Arizona Tempe Arizona 85283
Mary & Dick Allen Diabetes Center Newport Beach California 92663
Artemis Institute for Clinical Research San Diego California 92103
Encompass Clinical Research Spring Valley California 91978
Diablo Clinical Research, Inc. Walnut Creek California 94598
Lynn Institute of Denver Aurora Colorado 80012
Bridgeport Hospital Bridgeport Connecticut 06610
Yale University School of Medicine New Haven Connecticut 06519
Encore Medical Research Hollywood Florida 33024
Suncoast Research Group Miami Florida 33135
Onhealth Research Center Miami Florida 33186
Precision Clinical Research Sunrise Florida 33351
Einstein Clinical Research Vero Beach Florida 32960
ClinCept Clinical Research - MH Columbus Georgia 31904
Northeast Georgia Medical Center Gainesville Georgia 30501
Pivotal Research Solutions Stonecrest Georgia 30038
East-West Medical Research Institute Honolulu Hawaii 96814
Northwestern University Chicago Illinois 60611
Integrated Clinical Trial Services, Inc. West Des Moines Iowa 50265
Pennington Biomedical Research Center Baton Rouge Louisiana 70808
Great Lakes Research Group, Inc. Bay City Michigan 48706
Great Lakes Research Institute Southfield Michigan 48075
StudyMetrix Research City of Saint Peters Missouri 63303
Las Vegas Endocrinology Henderson Nevada 89074
Albany Medical College, Division of Community Endocrinology Albany New York 12203
New York Gastroenterology Associates New York New York 10075
Westchester Medical Center Valhalla New York 10595
PharmQuest Life Sciences, LLC Greensboro North Carolina 27408
Monroe Biomedical Research Monroe North Carolina 28112
Accellacare - Wilmington Wilmington North Carolina 28401
Lillestol Research Fargo North Dakota 58104
PriMED Clinical Research Dayton Ohio 45429
Tribe Clinical Research, LLC Greenville South Carolina 29607
WR-Clinsearch, LLC Chattanooga Tennessee 37421
Headlands Horizons LLC Brownsville Texas 78526
Next Level Urgent Care Houston Texas 77057
Houston Research Institute Houston Texas 77079
Consano Clinical Research, LLC Shavano Park Texas 78231
Chrysalis Clinical Research St. George Utah 84790
Charlottesville Medical Research Charlottesville Virginia 22911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06662383, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 12, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06662383 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →